Edwin Ampadu

Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial

Willemien A. Nienhuis, Ymkje Stienstra, William A. Thompson et al. · The Lancet · 2010 · 278 citations

Antimicrobial Susceptibility, Antibiotics, Antibacterial Agent +7

Distribution of Mycobacterium ulcerans in Buruli Ulcer Endemic and Non-Endemic Aquatic Sites in Ghana

Heather R. Williamson, M. Eric Benbow, Khoa Dang Nguyen et al. · PLoS neglected tropical diseases · 2008 · 148 citations · Full text

Pathology, Medical Microbiology, Non-endemic Aquatic Sites +16

Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of<i>Mycobacterium ulcerans</i>Disease

Fred Stephen Sarfo, Richard Odame Phillips, Kingsley Asiedu et al. · Antimicrobial Agents and Chemotherapy · 2010 · 115 citations · Full text

Surgery, Antimicrobial Chemotherapy, Dermatology +19

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass et al. · The Lancet · 2020 · 106 citations · Full text

Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism

Ymkje Stienstra, Tjip S. van der Werf, Elvira Oosterom et al. · Genes and Immunity · 2006 · 80 citations

Buruli Ulcer, Pathogenesis, Genetic Epidemiology +6